Product Information
SULFAMYLON 8.5% CREAM is a brand product labeled by Rising Pharma Holdings Inc., priced at $1.2343 per GM under NDC 16571072360. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
85 mg/g
Manufacturer
Rising Pharma Holdings Inc.NDC
16571072360
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
MAFENIDE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA016763On Market Since
5/18/2020
Pharmacological Classes
Price Statistics
The NADAC for SULFAMYLON 8.5% CREAM has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2343 per GM |
|---|---|
| All-time high | $1.2343 (Jun 24, 2026) |
| All-time low | $1.2141 (Nov 19, 2025) |
| 52-week high | $1.2343 |
| 52-week low | $1.2141 |
| Median price | $1.2238 |
| Average price | $1.2241 |
| Largest weekly change | +1.0% (Apr 22, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the mafenide acetate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SULFAMYLON 8.5% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for SULFAMYLON 8.5% CREAM, manufactured by Rising Pharma Holdings Inc., is $1.2343 per GM (NDC 16571072360), effective Jun 24, 2026.
How has the price of SULFAMYLON 8.5% CREAM changed over time?
Over the history we have for it, the NADAC for SULFAMYLON 8.5% CREAM has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SULFAMYLON 8.5% CREAM?
Since Apr 17, 2024, the NADAC for SULFAMYLON 8.5% CREAM has ranged from a low of $1.2141 (Nov 19, 2025) to a high of $1.2343 (Jun 24, 2026), with a median of $1.2238 per GM.
Are there cheaper alternatives to SULFAMYLON 8.5% CREAM?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SULFAMYLON 8.5% CREAM, so no direct lower-cost alternative is listed.
Who manufactures SULFAMYLON 8.5% CREAM?
SULFAMYLON 8.5% CREAM (NDC 16571072360) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification